HU V3 mirna codeset kit 12 RXN CSO-MIR3-12
Ended Awarded
- Contract number
- 75N91019F00132
- Awardee
-
Nanostring Technologies, Inc. UEI JEKKWSBFM2K4
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,007
Award facts
- Contract value 100% obligated
- $23,007.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339999 All Other Miscellaneous Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Seattle, WA 98119, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a BPA (Blanket Purchase Agreement) call contract to Nanostring Technologies, Inc. on April 11, 2019, for the supply of HU V3 miRNA Codeset Kit (12 reactions). This fixed-price contract with economic price adjustment carries a ceiling value of $23,007 and an ultimate completion date of April 10, 2020. The contract was awarded without a set-aside designation and will be performed in Seattle, Washington. Nanostring's miRNA codesets are specialized molecular biology reagents designed for use with the company's nCounter Analysis Systems, enabling researchers to detect and quantify microRNA expression patterns—a critical capability for cancer research and diagnostics.
This award reflects the National Cancer Institute's utilization of established procurement relationships with Nanostring for genomic analysis tools and consumables. Nanostring Technologies is a recognized provider of advanced multiplexed nucleic acid and protein detection platforms, with extensive experience supplying reagents, codesets, and analytical systems to the National Institutes of Health and other federal agencies. The miRNA codeset kits supplied under this contract support the Institute's translational research and molecular diagnostics initiatives, enabling NCI-funded researchers and partner institutions to conduct comprehensive gene expression profiling essential to understanding cancer biology and developing improved diagnostic and therapeutic approaches.
Quick answers
Who was awarded contract 75N91019F00132?
75N91019F00132 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on April 11, 2019.
How much is contract 75N91019F00132 worth?
The government has obligated $23,007 on 75N91019F00132.
Is contract 75N91019F00132 an order under another contract?
Yes. 75N91019F00132 is a BPA call under HHSN263201400050B, a blanket purchase agreement.
Was contract 75N91019F00132 competed?
The extent of competition for 75N91019F00132 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award